204 related articles for article (PubMed ID: 24845536)
1. Toxoplasma gondii infection of activated J774-A1 macrophages causes inducible nitric oxide synthase degradation by the proteasome pathway.
Padrão Jda C; Cabral GR; da Silva Mde F; Seabra SH; DaMatta RA
Parasitol Int; 2014 Oct; 63(5):659-63. PubMed ID: 24845536
[TBL] [Abstract][Full Text] [Related]
2. Reduced expression of the inducible nitric oxide synthase after infection with Toxoplasma gondii facilitates parasite replication in activated murine macrophages.
Lüder CG; Algner M; Lang C; Bleicher N; Gross U
Int J Parasitol; 2003 Jul; 33(8):833-44. PubMed ID: 12865083
[TBL] [Abstract][Full Text] [Related]
3. PPARalpha agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages.
Paukkeri EL; Leppänen T; Sareila O; Vuolteenaho K; Kankaanranta H; Moilanen E
Br J Pharmacol; 2007 Dec; 152(7):1081-91. PubMed ID: 17891158
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Nitric Oxide Production in Activated Macrophages Caused by
Cabral GRA; Wang ZT; Sibley LD; DaMatta RA
Front Microbiol; 2018; 9():1936. PubMed ID: 30177926
[No Abstract] [Full Text] [Related]
5. Toxoplasma gondii partially inhibits nitric oxide production of activated murine macrophages.
Seabra SH; de Souza W; DaMatta RA
Exp Parasitol; 2002 Jan; 100(1):62-70. PubMed ID: 11971655
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide inhibition after Toxoplasma gondii infection of chicken macrophage cell lines.
Guillermo LV; DaMatta RA
Poult Sci; 2004 May; 83(5):776-82. PubMed ID: 15141835
[TBL] [Abstract][Full Text] [Related]
7. Toxoplasma gondii infection induces apoptosis in noninfected macrophages: role of nitric oxide and other soluble factors.
Nishikawa Y; Kawase O; Vielemeyer O; Suzuki H; Joiner KA; Xuan X; Nagasawa H
Parasite Immunol; 2007 Jul; 29(7):375-85. PubMed ID: 17576367
[TBL] [Abstract][Full Text] [Related]
8. MAP kinase phosphatase-2 plays a key role in the control of infection with Toxoplasma gondii by modulating iNOS and arginase-1 activities in mice.
Woods S; Schroeder J; McGachy HA; Plevin R; Roberts CW; Alexander J
PLoS Pathog; 2013 Aug; 9(8):e1003535. PubMed ID: 23966857
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of nitric oxide production of activated mice peritoneal macrophages is independent of the Toxoplasma gondii strain.
Damasceno-Sá JC; de Souza FS; Dos Santos TAT; de Oliveira FC; da Silva MFS; Dias RRF; de Souza W; Arnholdt ACV; Seabra SH; DaMatta RA
Mem Inst Oswaldo Cruz; 2021; 116():e200417. PubMed ID: 33729328
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of susceptibility of chicken macrophages to infection with Toxoplasma gondii of type II and III strains.
Malkwitz I; Berndt A; Daugschies A; Bangoura B
Exp Parasitol; 2018 Apr; 187():22-29. PubMed ID: 29518451
[TBL] [Abstract][Full Text] [Related]
11. Inducible nitric-oxide synthase is regulated by the proteasome degradation pathway.
Musial A; Eissa NT
J Biol Chem; 2001 Jun; 276(26):24268-73. PubMed ID: 11312270
[TBL] [Abstract][Full Text] [Related]
12. Toxoplasma gondii exposes phosphatidylserine inducing a TGF-beta1 autocrine effect orchestrating macrophage evasion.
Seabra SH; de Souza W; Damatta RA
Biochem Biophys Res Commun; 2004 Nov; 324(2):744-52. PubMed ID: 15474490
[TBL] [Abstract][Full Text] [Related]
13. TgMAPK1 is a Toxoplasma gondii MAP kinase that hijacks host MKK3 signals to regulate virulence and interferon-γ-mediated nitric oxide production.
Brumlik MJ; Pandeswara S; Ludwig SM; Jeansonne DP; Lacey MR; Murthy K; Daniel BJ; Wang RF; Thibodeaux SR; Church KM; Hurez V; Kious MJ; Zhang B; Alagbala A; Xia X; Curiel TJ
Exp Parasitol; 2013 Jul; 134(3):389-99. PubMed ID: 23541881
[TBL] [Abstract][Full Text] [Related]
14. Production of nitric oxide (NO) is not essential for protection against acute Toxoplasma gondii infection in IRF-1-/- mice.
Khan IA; Matsuura T; Fonseka S; Kasper LH
J Immunol; 1996 Jan; 156(2):636-43. PubMed ID: 8543815
[TBL] [Abstract][Full Text] [Related]
15. CHIP facilitates ubiquitination of inducible nitric oxide synthase and promotes its proteasomal degradation.
Chen L; Kong X; Fu J; Xu Y; Fang S; Hua P; Luo L; Yin Z
Cell Immunol; 2009; 258(1):38-43. PubMed ID: 19362296
[TBL] [Abstract][Full Text] [Related]
16. LDL and UV-oxidized LDL induce upregulation of iNOS and NO in unstimulated J774 macrophages and HUVEC.
Persson K; Sauma L; Säfholm A; Xu L; Li W; Yuan XM
APMIS; 2009 Jan; 117(1):1-9. PubMed ID: 19161531
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice.
Schlüter D; Deckert-Schlüter M; Lorenz E; Meyer T; Röllinghoff M; Bogdan C
J Immunol; 1999 Mar; 162(6):3512-8. PubMed ID: 10092808
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide is an important regulator of heme oxygenase-1 expression in the lipopolysaccharide and interferon-γ-treated murine macrophage-like cell line J774.1/JA-4.
Koike A; Minamiguchi I; Fujimori K; Amano F
Biol Pharm Bull; 2015; 38(1):7-16. PubMed ID: 25744452
[TBL] [Abstract][Full Text] [Related]
19. Inducible nitric-oxide synthase and nitric oxide donor decrease insulin receptor substrate-2 protein expression by promoting proteasome-dependent degradation in pancreatic beta-cells: involvement of glycogen synthase kinase-3beta.
Tanioka T; Tamura Y; Fukaya M; Shinozaki S; Mao J; Kim M; Shimizu N; Kitamura T; Kaneki M
J Biol Chem; 2011 Aug; 286(33):29388-29396. PubMed ID: 21700708
[TBL] [Abstract][Full Text] [Related]
20. Bryostatin-1 and IFN-gamma synergize for the expression of the inducible nitric oxide synthase gene and for nitric oxide production in murine macrophages.
Taylor LS; Cox GW; Melillo G; Bosco MC; Espinoza-Delgado I
Cancer Res; 1997 Jun; 57(12):2468-73. PubMed ID: 9192827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
